Holen Sie sich die Stockscreener-App
10.83
0.18%
-0.02
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
Aug Mood: Is Emergent BioSolutions Inc stock showing strong momentumJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
What's Going On With Emergent BioSolutions Friday?Emergent BioSolutions (NYSE:EBS) - Benzinga
Emergent BioSolutions Says FDA Approves Supplemental NDA for Nasal Spray Product - marketscreener.com
Emergent BioSolutions (EBS) Expands NARCAN Nasal Spray Offering with FDA Approval - GuruFocus
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks - Yahoo Finance
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Bitget
Will Emergent BioSolutions Inc. benefit from green energy policiesJuly 2025 Rallies & Low Drawdown Trading Techniques - mfd.ru
Emergent BioSolutions Inc. to Host Conference Call on Q4 and Full Year 2025 Financial Results - Quiver Quantitative
Emergent Biosolutions Inc. $EBS Shares Purchased by Allianz Asset Management GmbH - MarketBeat
Emergent BioSolutions Receives FDA Approval for New NARCAN® Nasal Spray Multipacks - Intellectia AI
Can Emergent BioSolutions Inc. stock outperform in a bear marketJuly 2025 Review & Low Risk High Reward Trade Ideas - mfd.ru
How strong dollar benefits Emergent BioSolutions Inc. stockJuly 2025 Snapshot & Capital Efficient Trade Techniques - mfd.ru
New York State Common Retirement Fund Has $4.60 Million Stock Holdings in Emergent Biosolutions Inc. $EBS - MarketBeat
How Emergent Biosolutions Inc. (EBS) Affects Rotational Strategy Timing - Stock Traders Daily
NYAG's Insider Trading Case A Power Grab, Judge Told - Law360
Retail Surge: Can Emergent BioSolutions Inc stock outperform in a bear marketPortfolio Value Summary & Free Community Consensus Stock Picks - baoquankhu1.vn
Federated Hermes Inc. Raises Position in Emergent Biosolutions Inc. $EBS - MarketBeat
Emergent BioSolutions Inc. (EBS) Stock Analysis: Evaluating a 13.45% Upside Potential Amidst Sector Challenges - DirectorsTalk Interviews
Emergent Biosolutions (NYSE:EBS) Share Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Why is Emergent BioSolutions Inc stock going downJuly 2025 Market Mood & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Market Review: Is Emergent BioSolutions Inc stock showing strong momentumWeekly Stock Analysis & Daily Entry Point Alerts - baoquankhu1.vn
Lipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies - GlobeNewswire Inc.
Emergent BioSolutions Inc. (EBS) Stock Analysis: Is The 11.66% Upside Worth The Risk? - DirectorsTalk Interviews
Emergent Biosolutions (NYSE:EBS) Share Price Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat
Biotech Co. Gets OK For $10M Stalking Horse Bid - Law360
Emergent BioSolutions (EBS) receives a new order from US Department of War - MSN
Bispecific Antibody Market with Insights from Immunomedics, - openPR.com
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing - FinancialContent
Former biotech CEO sued over COVID vaccine alleged insider trading - AOL.com
Moving Averages: Will Norfolk Southern Corporation outperform tech stocksJuly 2025 Catalysts & Safe Entry Trade Signal Reports - baoquankhu1.vn
Ex-Biotech CEO Cashed In $10M Ahead Of COVID Vaccine Crisis: Lawsuit - AOL.com
JPM movers: ImmunityBio rises to the top - BioCentury
FRAUD AND MANIPULATION—N.Y. Sup.: New York’s AG sues former Emergent BioSolutions CEO for insider trading - VitalLaw.com
Insider Sell: Can BOS Better Online Solutions Ltd disrupt its industryPortfolio Value Summary & AI Driven Price Forecasts - baoquankhu1.vn
Retail Trends: Is CMREPRC stock technically oversoldEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn
Lobbying Update: $430,000 of EMERGENT BIOSOLUTIONS INC lobbying was just disclosed - Quiver Quantitative
New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading - The New York Times
Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading - BioPharma Dive
Emergent BioSolutions (EBS) Receives a New Order from US Department of War - Insider Monkey
Emergent BioSolutions (EBS) Sued for Insider Trading, Agrees to $900K Settlement - Intellectia AI
Read This Before Judging Emergent BioSolutions Inc.'s (NYSE:EBS) ROE - Yahoo Finance
Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 23% Upside Potential and Robust Free Cash Flow - DirectorsTalk Interviews
Ex-CEO sued by New York for insider trading tied to COVID-19 vaccine contamination - whtc.com
New Packaging Option for Narcan Nasal Spray Aims to Reduce Stigma - Psychiatry Advisor
Ex-CEO Of COVID Vax Maker Accused Of Insider Trading - Law360
Emergent Biosolutions Stock Plummets Amid Insider Trading Allegations Against Former CEO - Stocktwits
NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading - The Wall Street Journal
Ex-CEO sued by New York for insider trading tied to COVID vaccine contamination - Reuters
NY Sues Ex-Emergent BioSolutions CEO for Insider Trading (1) - Bloomberg Law News
Emergent Biosolutions (NYSE:EBS) Stock Price Down 7.4%What's Next? - MarketBeat
1.19%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):